ARTICLE | Targets & Mechanisms
Meet the METs
June 16, 2011 7:00 AM UTC
Researchers at Queen Mary, University of London have found that blocking endocytosis could treat MET-mutant cancers resistant to current treatments.1 Developing a safe way to inhibit the essential cellular process could prove challenging.
Endocytosis is a process by which the cell takes up extracellularmolecules including proteins for recycling or degradation. The process influences cell migration, survival and receptor signaling.2,3...